Manuscripts
Showing 1549 manuscripts.
Effects of combination antiretroviral therapy and nutritional rehabilitation on growth in children aged 6-36 months with severe acute malnutrition in IMPAACT protocol P1092
Citation
Christina Reding, Frederic Bone, Sarah Bradford, Diane Costello, Renee Browning, John Moye, Tichaona Vhembo, Sharon Mambiya, Esnath Msowoya, Maxensia Owor, Philippa Musoke, Blandina Theophil Mmbaga, James Samwel Ngocho, Camlin Tierney, Lauren Ziemba. Effects of combination antiretroviral therapy and nutritional rehabilitation on growth in children aged 6-36 months with severe acute malnutrition in IMPAACT protocol P1092. Journal of Paediatric Infectious Diseases. 2024. PMID: 38808862Year
2024
Journal
Journal of Paediatric Infectious Diseases
Study
P1092
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Citation
Kristin Baltrusaitis, Jenny Huang, Barbara Heckman, Sarah Buisson, Dwight E. Yin, Ryan Milligan, Allison Agwu, Shawn Ward, Rohan Hazra, Carolyn Bolton-Moore, Conn Harrington, Aditya H. Gaur, Rodica M. Van Solingen-Ristea, IMPAACT 2017 Team, Cynthia C. McCoig, Adeola Adeyeye, Jared Kneebone, Vasiliki Chounta, Christiana Smith-Anderson, Elizabeth D. Lowenthal, Andres Camacho-Gonzalez, Jennifer Chapman, Ellen Chadwick, Rachel Ohrenschall, Allison Bearden, Katherine Calabrese, Herta Crauwels. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study. Lancet HIV. 2024. 11: e222-e232. PMID: 38538161Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV
Citation
Roger Shapiro, Jeff Stringer, Grace Malonga, Renee Browning, Nahida Chakhtoura, Blandina Theophil Mmbaga, Tsungai P Mhembere, Ayotunde Omoz-Oarhe, Beatrice Nagaddya, Megeshinee Naidoo, Risa M Hoffman, Lee Fairlie, Shahin Lockman, Sean Brummel, IMPAACT 2010/VESTED Study Team, Lauren Ziemba, Anne Coletti, Lameck Chinula. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. Journal of the International AIDS Society. 2024. 97: 150-155. PMID: 39742354Year
2024
Journal
Journal of the International AIDS Society
Study
IMPAACT 2010
Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life
Citation
Deborah Persaud, Ellen G. Chadwick, Jennifer Jao, IMPAACT P1115 Team, Mark F. Cotton, Yvonne Bryson, Anne Coletti, Theodore D. Ruel, Stephen A. Spector, Christina Reding, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Bryan S. Nelson, Dwight E. Yin, Camlin Tierney, Patrick Jean-Philippe. Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 2023. 76: e744-e747. PMID: 36031390Year
2023
Journal
Clinical Infectious Diseases
Study
P1115
Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014
Citation
Hong Wan, Hedy Teppler, Kathryn P Gray, Ellen Townley, Mounika Yedla, Jack Moye, Brookie M. Best, Nicole H. Tobin, IMPAACT 2014 Study Team, Havilland Campbell, Katie McCarthy, Rachel Scheckter, Linda Aurpibul, Pradthana Ounchanum, Supattra Rungmaitree, Hassena Cassim, Elizabeth McFarland, Patricia Flynn, Ann J Melvin, Ellen Cooper, Ka Lai Yee, Chelsea Krotje. Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014. Journal of AIDS. 2023. PMID: 36215957Year
2023
Journal
Journal of AIDS
Study
IMPAACT 2014
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India
Citation
David E. Shapiro, Patience Atuhaire, Taha E Taha, Bonus Makanani, Lameck Chinula, Maxensia Owor, Dhayendre Moodley, Tsungai Chipato, Katie McCarthy, Patricia M. Flynn, Judith Currier, Mary Glenn Fowler, Amita Gupta, Nishi Suryavanshi, Neetal Nevrekar, Kevin Butler. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India. Journal of the International AIDS Society. 2023. 92: 76-83. PMID: 36170749Year
2023
Journal
Journal of the International AIDS Society
Study
1077FF, 1077BF
Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19
Citation
Kristina Brooks, Brookie M Best, Diana F Clarke, Mark Mirochnick, John N van den Anker, Edmund V Capparelli, Jeremiah D Momper, Xiaomei Liu, André Dallmann. Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19. CPT: pharmacometrics & systems pharmacology. 2023. 12: 148-153. PMID: 36479969Year
2023
Journal
CPT: pharmacometrics & systems pharmacology
Study
IMPAACT 2032
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
Citation
James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team, Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati. Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023. PMID: 36650479Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1078
Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia
Citation
International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team, Jean Rene Anderson, Deborah Kacanek, Yanling Huo, Kevin Psoter, Lisa R Yanek, Khalil Ghanem, Irina Burd, Anna Maya Powell, Deborah Persaud. Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia. American Journal of Reproductive Immunology. 2023. PMID: 36680487Year
2023
Journal
American Journal of Reproductive Immunology
Study
P1025
HIV-1 Remission and Possible Cure in a Woman after Haplo-Cord Blood Transplant
Citation
Lawrence D Petz, Marshall J. Glesby, Renee Browning, Savita Pahwa, Deborah Persaud, Anne Coletti, Yvonne Bryson, Meredith G. Warshaw, IMPAACT P1107 Team, Theodore B. Moore, Ya Hui Chen, Suresh Pallikkuth, Adit Dhummakupt, Ruth Cortado, Amanda Golner, Frederic Bone, Maria Baldo, Marcie Riches, Jingmei Hsu, John W. Mellors, Koen Van Besien, Nicole H. Tobin. HIV-1 Remission and Possible Cure in a Woman after Haplo-Cord Blood Transplant. Cell. 2023. 186: 1115-1126.Year
2023
Journal
Cell
Study
P1107